domingo, 30 de enero de 2011
Call for Public Review: The Impact of Pre-Transplant Red Blood Cell Transfusions in Renal Allograft Rejection and Health Risk Appraisal -
Call for Public Review:
1. The Impact of Pre-Transplant Red Blood Cell Transfusions in Renal Allograft Rejection
2. Health Risk Appraisal
The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment (TA) Program develops systematic reviews, health technology assessments, and other reports at the request of the Centers for Medicare & Medicaid Services (CMS) Coverage and Analysis Group. These reports are funded by an Interagency Agreement from CMS to AHRQ and used to inform national coverage policies, discussion at public Medicare Evidence Development and Coverage Advisory Committee (MedCAC) meetings, and/or for other policy considerations.
To get complete public review, the AHRQ TA Program will post draft reports on the AHRQ TA Web site. To meet the timelines for Medicare coverage decisions mandated by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, draft technology assessment reports will be available for public review for a limited time. A notice will be sent out on the CMS Medicare Coverage and AHRQ Effective Health Care E-mail distribution lists 1 week before the posting of draft reports. Each report will be available for public review on this Web site for a total of 2 weeks.
AHRQ's TA Program supports and is committed to the transparency of its review process. Therefore, starting March 18, 2009, invited peer review comments and public review comments will be publicly posted on the TA Program Web site at http://www.ahrq.gov/clinic/techix.htm within 3 months after the associated final report is posted on this Web site. The report authors' responses to the comments (the "disposition of comments") will be posted on the same Web page as the associated comments.
When a draft Technology Assessment report is available for review, you may review the draft report by completing the associated review form and then selecting "Submit" on the form.
Note: Comments received after the review period will not be accepted.
Currently Available for Review
The Impact of Pre-Transplant Red Blood Cell Transfusions in Renal Allograft Rejection (PDF file, 1.6 MB; PDF Help)
Date Available: 9:00 AM, January 20, 2011, to 5:00 PM, February 3, 2011.
Health Risk Appraisal (PDF file, 2.8 MB; PDF Help)
Date Available: 9:00 AM, January 26, 2011, to 5:00 PM, February 9, 2011.
Persons with disabilities experiencing problems accessing portions of the PDF files for draft reports should contact the Technology Assessment Program at firstname.lastname@example.org.
If you have any problems with your submission, please E-mail your comments along with a statement indicating your acceptance of the AHRQ Technology Assessment Program Public Review disclosure policy to email@example.com. Thank you.
Effectiveness of Cochlear Implants in Adults with Sensorineural Hearing Loss
Date Available: 9:00 AM, February 2, 2011, to 5:00 PM February 16, 2011.
Please contact firstname.lastname@example.org if you have any questions.
Current as of January 2011
Call for Public Review. Agency for Healthcare Research and Quality, Rockville, MD.
Call for Public Review